MENLO PARK, Calif. , Feb. 11, 2019 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its fourth quarter and year ended December 31, 2018 , as attached. During the fourth quarter of 2018, the Company stated that it was targeting early

Improved Reference Genome for Aedes aegypti, Carrier of Zika Virus and Other Public Health Threats, Published in Nature MENLO PARK, Calif. , Nov. 14, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California Inc. , (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes,

MENLO PARK, Calif. , Nov. 01, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2018 . Total revenue for the third quarter of 2018 was $18.2 million , compared to $23.5 million for the third

Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome Pacific Biosciences’ Recent Advances with its Sequel SMRT ® Technology, Combined with Illumina’s Infrastructure, will Expand Biological Discovery and Clinical Insight

MENLO PARK, Calif. , Oct. 16, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2018 Financial Results on Thursday, November 1, 2018 , at 4:30pm Eastern Time .

Highlights include release of new chemistry and more than 25 presentations demonstrating utility of SMRT Sequencing for human genetics applications MENLO PARK, Calif. , Oct. 15, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality

Significant Enhancements to Sequel System Enable >99% Accuracy for Single-Molecule Reads up to 15 kb ; Throughput Increases by 2- to 4-Fold MENLO PARK, Calif. , Oct. 10, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing

Diploid Assembly of a Puerto Rican Female Adds a Rich Resource to Population-Specific Reference Genomes MENLO PARK, Calif. , Oct. 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and

High-quality reference genomes for thousands of plant, animal and microbial species to be created using SMRT Sequencing MENLO PARK, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) -- When creating a genomic ark of creatures great and small, scientists across the globe are turning to the comprehensive

MENLO PARK, Calif. , Sept. 12, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”) today announced that it has priced its previously announced underwritten public offering of 14,117,647 shares of its common stock at a price to the public of $4.25 per